Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma published in The Lancet Oncology.

American Association for Anatomy Newsletter Member Spotlight featuring Michael Hortsch

New publication from Pedro Lowenstein and Maria Castro's labs

A University of Michigan Health study suggests stroke transfer times are much longer than recommended.

17 percent of patients seeing a Neurologist report they travel long distances.

A Michigan Medicine study finds older Americans with complex neurologic conditions travel may travel great distances for care, many of whom live in rural areas or regions with a limited number of specialists.

How much melatonin should I take? Experts weigh in on dosage rules and how much is too much.

Developing Future Biologists (DFB) is recruiting new instructors

Connect with the Department of Cell and Developmental Biology on LinkedIn

Learn about a new book chapter coauthored by Michael Hortsch

Congratulations to Takashi Hotta for his promotion to Research Assistant Professor.

Study: Spinal Cord Stimulation Offers Unmatched Pain Relief for Diabetic Neuropathy

Research from the University of Michigan Department of Neurosurgery and Rogel Cancer Center shows promising early results that a therapy combining cell-killing and immune-stimulating drugs are safe and effective in extending survival for patients with gliomas, a highly aggressive form of brain cancer.

The largest study of brains of athletes younger than 30 found early signs of CTE even in amateur players.

University of Michigan experts explore the mystery of why some people develop ALS.